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Abstract The role of aquaporin-4 (AQP4) and
interleukin-6 (IL-6) in the development of brain edema
post-traumatic brain injury (TBI) has been indicated.
The present study was designed to investigate the ef-
fect(s) of administration of progesterone (P) and/or es-
trogen (E) on brain water content, AQP4 expression,
and IL-6 levels post-TBI. The ovariectomized rats were
divided into 11 groups: sham, one vehicle, two vehicles,
E1, E2, P1, P2, E1 + P1, E1 + P2, E2 + P1, and E2 + P2.
The brain AQP4 expression, IL-6 levels, and water
content were evaluated 24 h after TBI induced by
Marmarou’s method. The low (E1 and P1) and high
(E2 and P2) doses of estrogen and progesterone were
administered 30 min post-TBI. The results showed that
brain water content and AQP4 expression decreased in
the E1, E2, P1, and P2-treated groups. The administra-
tion of E1 decreased IL-6 levels. Addition of progester-
one decreased the inhibitory effect of E1 and E2 on the
accumulation of water in the brain. Administration of E1
+ P1 and E1 + P2 decreased the inhibitory effect of E1
on the IL-6 levels and AQP4 protein expression. Our
findings suggest that estrogen or progesterone by itself
has more effective roles in decrease of brain edema than
combination of both. Possible mechanism may be me-
diated by the alteration of AQP4 and IL-6 expression.
However, further studies are required to verify the exact
mechanism.
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Introduction
In definition, the brain edema is an increase of fluid
within the brain tissue; it is regarded with types of
vasogenic and cytotoxic. Vasogenic edema results
from blood-brain barrier destruction that leads to
fluid accumulation in brain. Cytotoxic edema arises
from fluid increase within cell cytoplasm as a result
of injury [20]. In moderate to severe brain injury, the
untreated cerebral edema leads to high morbidity
and mortality [8]. Current therapeutic methods do
not control cerebral edema efficiently. These limita-
tions emphasize the need for novel approaches to
prevent or decrease cerebral edema.
Recently, it has been shown that the aquaporins
(AQPs) participate in the pathophysiology of the brain
edema [9, 18, 23]. The AQPs are water channels that
provide a key path for transcellular water movement in
many cell types [1]. It has been proved that aquaporin-
4 (AQP4) is the most predominant form of AQP
family expressed in the brain and plays an important
role in the development of edema [34]. A gross agree-
ment exists among the experts that AQP4 is involved
both in brain edema formation and in its clearance,
although the exact mechanisms remain unclear. Recent
studies have demonstrated that the expression of
AQP4 markedly enhanced in cerebral edema, suggest-
ing a crucial role for this channel in the exacerbation
of edema [9, 32]. AQP4-deficient mice have exhibited
less brain edema and better survival following cerebral
ischemia or acute water intoxication, than wild-type
mice [3].
Traumatic brain injury (TBI) is also associated
with increasing levels of pro-inflammatory cyto-
kines that have a role in the development of cerebral
edema [4]. The inflammation contributes in post-
traumatic neurological deterioration [17]. Brain
interleukin-6 (IL-6) increases in TBI [10]. Our pre-
vious studies have also demonstrated increasing IL-
6 after experimental TBI [15, 25]. Several investi-
gators have suggested that increasing IL-6 may be
involved in the development of other post-trauma
responses, including the brain edema [37, 39].
Interestingly, some of the cytokines have the ability
to upregulate the AQP4 expression [2, 17].
Intracerebral administration of interleukin-1β (IL-
1β) has led to increasing AQP4 expression via acti-
vation of nuclear factor kappa b (NFκB) [13].
Several clinical researchers have shown that the
menopausal women are vulnerable to different in-
sults which are characterized by the development of
brain edema including ischemic brain injury, com-
pared to young women [19, 36]. Multiple studies
have clearly shown that estradiol (E2) may be re-
sponsible for these differences [15, 42]. It has been
demonstrated that the female brain is resistant to
ischemic injury during the reproductive period com-
pared to that of male and that estrogen plays an
important role in this neuroprotection [33]. It has
been suggested that progesterone decreases the brain
edema and increases the functional recovery after
TBI in animal models of the injury [7, 26]. Recent
experiments have also demonstrated that estrogen
and progesterone lower the levels of inflammatory
cytokines and cell death after TBI [5, 25]. The
lesion volume decreases in TBI females compared
to males. The administration of estrogen and pro-
gesterone decreases brain edema in males and ovari-
ectomized rodents [8, 26]. The changes of AQP4
have been demonstrated following the administra-
tion of estrogen and progesterone in experimental
brain injury [8, 29].
Despite demonstrated benefits in the decrease of
brain edema after TBI, it is not exactly known how
progesterone and estrogen specifically produce these
beneficial effects at the cellular level. Also, few
studies have evaluated estrogen and progesterone
effects on the brain edema associated with the
AQP expression and the IL-6 levels post-TBI. In
the mind, the present study was designed to analyze
the development of brain edema, the expression of
brain AQP4, and the intracerebral concentration of
IL-6 in response to the administration of progester-
one and estrogen (at low and high levels), alone and
in combination, following diffuse traumatic brain
injury in the ovariectomized rats. Our goal in this
study was to determine the neuroprotective mecha-
nism of ovarian hormones in experimental TBI.
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Materials and methods
Animals
The study was conducted in accordance with proto-
col approved by the ethics committee (No. EC/
KNRC/86-30) of Kerman University of Medical
Sciences, in accordance with internationally ap-
proved principles for laboratory animal use and care,
as found in the European Community Guidelines
(EEC Directive of 1986; 86/609/EEC) or US guide-
lines (NIH publication #85-23, revised in 1985).
Animals (mature female Wistar rats, weighing 200–
250 g) were housed in an air-conditioned room at
22–25 °C, with a 12 h light/12 h dark cycle and free
access to food and water.
Method of bilateral ovariectomy
All study animals were ovariectomized (OVX) to avoid
interferences due to the estrus cycle, 2 weeks before the
experiments, as previously described [15]. Briefly, an
incision with a length of 2 cm was created in the sub-
abdominal part of the anesthetized animals. Then, the
tube of uterus and vascular base of ovaries were twisted
around proximal area and were cut from distal area.
Finally, the muscles and skin were replaced back and
stitched.
Animal groups
The OVX animals were randomly divided into 11
groups (n=12 in each group): (i) sham group; (ii) one-
vehicle group: OVX rats received an injection of an
equal volume of vehicle (sesame oil which used as
estrogen or progesterone solvent); (iii) two-vehicle
group: OVX rats received an injection of two equal
volumes of vehicle (sesame oil which was used as
estrogen and progesterone solvent); (iv) E1 group:
Animals received an injection of a low dose of estrogen
(33.3 μg/kg); (v) E2 group: Rats received an injection of
a high dose of estrogen (1 mg/kg); (vi) P1 group: Rats
received an injection of a low dose of progesterone
(1.7 mg/kg); (vii) P2 group: Rats received an injection
of a high dose of progesterone (8 mg/kg); (viii) E1 + P1
group: Rats received a combined injection of low doses
of estrogen and progesterone; (ix) E1 + P2 group: Rats
received a combined injection of a low dose of estrogen
and a high dose of progesterone; (x) E2 + P1 group: Rats
received a combined injection of a high dose of estrogen
and a low dose of progesterone; and (xi) E2 + P2 group:
Rats received a combined injection of high doses of
estrogen and progesterone. It should be mentioned that
the treatment was performed as an intraperitoneal injec-
tion (i.p.), a half of hour post-TBI [22].
Model of diffuse TBI
The anesthetized animals (with thiopental, 50 mg/kg,
i.p.) were intubated before injury. TBI was induced as
we have previously described in our articles [15].
Briefly, TBI was induced by the Marmarou method
using a TBI induction device made at home
(Department of Physiology, Kerman University of
Medical Sciences). TBI was moderate and diffuse type.
The rats were connected to respiratory pump, post-
trauma (TSA animal respiratory compact, Germany).
The intratracheal tube was removed after restoration of
spontaneous breathing, and the rat was placed in an
individual cage, following recovery.
Determination of brain water content
The brain edema was assessed by measuring the brain
water content in each animal as previously described
[15]. Briefly, brain wet and dry weights were acquired.
Then, percentage of water was calculated in each sample
using an equation: 100 %×[(wet weight−dry weight)/
wet weight].
Measurement of brain IL-6 levels
The brains in rats anesthetized with thiopental
(50 mg/kg, i.p.) were quickly removed and immediately
frozen in liquid nitrogen, 24 h after TBI [11]. The brain
samples were weighed and homogenized in tissue pro-
tein extraction reagent (T-PER) with 0.5 % Triton
X-100, 150mmol/LNaCl, 50mmol/LTris, and protease
inhibitor cocktail (Pierce) (500mg tissue per 1 mL of the
reagent). Following homogenization, the samples were
shaken for 90 min and then centrifuged for 15 min (4 °C
and 4000 g). The supernatant was collected, and the
protein content of supernatant was estimated to ensure
that an equal amount of protein from each sample was
used for the assay, using BCA Protein Assay Reagent kit
[35]. IL-6 was measured by enzyme-linked immunosor-
bent assay (ELISA) kit (BMS, Austria) according to the
protocol provided by the manufacturer. The
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concentration of IL-6 was quantified as picogram of
antigen per milliliter of supernatant for each sample.
Reverse transcription-polymerase chain reaction
of AQP4
AQP4 gene analysis in the brain was performed by
reverse transcription-polymerase chain reaction (RT-
PCR). Total RNAwas extracted from each brain sample
and reverse transcribed into the cDNA. Beta-actin (β-
actin) was used as the internal control. The sequences of
the upstream and downstream primers for β-actin were
5′-TCG-TGG-GCC-GCC-CTA-GGC-AC-3′ and 5′-
GGC-CTT-AGG-GTT-CAG-AGG-GGC-3 ′ ,
respectively, and those for AQP4 were 5′-CCT-CTA-
CCT-GGT-CAC-ACC-C-3′ and 5′-GTC-CTT-CCC-
CTT-CTT-CTC-G-3′. After 2 % agarose gel electropho-
resis, the gray scales of PCR amplification products
(PCR kit, Germany Roche) were analyzed using Band
Leader 3.0 Gel Image Manipulation software (http://
www.bio-soft.net/draw/BandLeader.htm, accessed
December 20, 2012). The relative messenger RNA
(mRNA) of gene of interest was presented as ratio of
the band gray scale of AQP4 to that of the β-actin for
each sample [41].
Western blotting of AQP4
The AQP4 protein expression in the brain was quanti-
fied by Western blot. The homogenized brain sample
was centrifuged for 30 min (12,000×g at 4 °C). Protein
concentration of the supernatant was measured, and
equal amounts of protein in each sample were subjected
to 12 % sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) before being transferred
to a nitrocellulose membrane. The membrane was
blocked with 5 % fat-free milk at room temperature
(RT) for 2.5 h and then incubated with rabbit polyclonal
anti-AQP4 (1:500, Sigma, USA; cat. # A5971) at 4 °C
overnight. The membrane was incubated with HRP-
linked goat anti-rabbit IgG (1:1000, Sigma, USA; cat.
# A9169) at RT for 2 h, following three washes. ECL kit
(Roche, Germany) was used to visualize chemilumines-
cent signal bands. The membrane was exposed to the
radiography film to reveal the AQP4 band (30 kDa). A
Fig. 1 a Effect of estrogen or progesterone on brain water content
(%) following traumatic brain injury (TBI) in the ovariectomized
(OVX) rats (n=6 in each group). ***p<0.001, all groups vs.
vehicle group. ###p<0.001, E2 group vs. all groups. b Effect of
low dose of estrogen (alone and combined administration) on the
percentage changes of brain water content compared with that in
vehicle, following TBI in the OVX rats (n=6 in each group).
*p<0.05, E1 group vs. E1 + P2 group. c Effect of high dose of
estrogen (alone and combined administration) on the percentage
changes of brain water content compared with that in vehicle,
following TBI in the OVX rats (n=6 in each group).
***p<0.001, E2 group vs. E2 + P1 or E2 + P2 groups. Veh
vehicle, E1 low dose of estrogen, E2 high dose of estrogen, P1
low dose of progesterone, P2 high dose of progesterone, E1 + P1
low dose of estrogen + low dose of progesterone, E1 + P2 low
dose of estrogen + high dose of progesterone, E2 + P1 high dose
of estrogen + low dose of progesterone, E2 + P2 high dose of
estrogen + high dose of progesterone. Data are presented as mean
±SEM
Fig. 2 Effect of estrogen or
progesterone on the brain AQP
mRNA (fold) following traumatic
brain injury (TBI) in the
ovariectomized (OVX) rats (n=6
in each group). **p<0.01, E2
group vs. vehicle group. *p<0.05,
P1 and P2 groups vs. vehicle
group. Veh vehicle, E1 low dose
of estrogen, E2 high dose of
estrogen, P1 low dose of
progesterone, P2 high dose of
progesterone. Data are presented
as mean±SEM. Reverse
transcription-polymerase chain
reaction was the evaluation
method of AQP4 mRNA
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computer-assisted image analysis system (Gel Pro
Analyzer 4.0, Media Cybernetics, USA) was used to
analyze the integrated densities. The β-actin band was
used to normalize the AQP4 expression [4] using
anti-β-actin (Sigma, USA; cat. # A2668).
Statistical analysis
All data were analyzed for normality by Shapiro-
Wilk’s W test. The percentage change in each sam-
ple was calcu la ted by us ing an equat ion:
100 %×[(amount vehicle group−amount of hor-
mone group)/amount of vehicle group]. The quanti-
tative data are expressed as mean±SEM. The data
were analyzed by parametric analysis of variance
(ANOVA). ANOVA post hoc analysis of the vari-
ables was performed using Tukey test; if homoge-
neity in variances existed otherwise, Games-Howell
test was used. ANOVA post hoc analysis of changes
was performed using Dunnett test. The criterion for
statistical significance was set at p<0.05.
Results
Brain water content following treatment in TBI
The effect of different doses of ovarian steroid hor-
mones on the brain water content post-TBI in the ovari-
ectomized rats is shown in Fig. 1. The brain water
content significantly decreased in E1, E2, P1, and P2
groups compared with the vehicle group (78.84±
0.22 %, p<0.001). In addition, the brain water content
was statistically different between the E2 group (70.8±
0.15 %) and the other groups (p<0.001) (Fig. 1a). The
effect of low or high dose of estrogen (alone and com-
bined administration) on the percentage changes of
brain water content compared with that in the vehicle
group is shown in Fig. 1b, c. A low dose of estrogen
decreased brain water content (−2.41±0.52 %) com-
pared with that in the E1 + P2 group (0.69±0.4 %,
p<0.05). The brain water content (−2.1±0.87 %) was
not statistically different between the E1 + P1 group and
the E1 group (Fig. 1b). The brain water content signif-
icantly decreased in the E2 group (−10.19±0.37 %)
compared with that in the E2 + P1 (−1.45±0.73 %)
and E2 + P2 (−2.67±0.87 %) groups (p<0.001)
(Fig. 1c).
Brain AQP4 mRNA following treatment in TBI
The effect of different doses of ovarian steroid hor-
mones on the brain AQP4 mRNA post-TBI in the
ovariectomized rats is shown in Fig. 2. The AQP4
mRNA was significantly decreased in the E2 (0.52±
0.17, p<0.01), P1 (0.88±0.1, p<0.05), and P2 (0.88
±0.06, p<0.05) groups compared with that in the
vehicle group (1.83±0.2), while the AQP4 mRNA
was not significantly different between the E1 group
(1.69±0.29) and the vehicle group. The effect of
low or high dose of estrogen (alone and combined
administration) on the percentage changes of AQP4
mRNA compared with that in the vehicle-treated
group was analyzed. This analysis was not signifi-
cant (data not shown).
Brain AQP4 protein following treatment in TBI
The effect of different doses of ovarian steroid hor-
mones on the brain AQP4 protein post-TBI in the
ovariectomized rats is shown in Fig. 3. The AQP4
protein significantly decreased in the E1 (9.7±1.07,
p<0.001), E2 (8.85±1.55, p<0.001), P1 (16.45±
1.77, p<0.05), and P2 (12.99±2.09, p<0.01) groups
compared with that in the vehicle group (25.38±
3.25) (Fig. 3a). The percentage changes of AQP4
protein in the group treated with low or high dose of
estrogen (alone and combined administration) com-
pared with that in the vehicle group is shown in
Fig. 3 a Effect of estrogen or progesterone on the brain AQP
protein (%) following traumatic brain injury (TBI) in the
ovariectomized (OVX) rats (n=6 in each group). ***p<0.001,
E1 and E1 groups vs. vehicle group. **p<0.01, P2 group vs.
vehicle group. *p<0.05, P1 group vs. vehicle group. b Effect of
low dose of estrogen (alone and combined administration) on the
percentage changes of AQP protein compared with that in vehicle,
following TBI in the OVX rats (n=6 in each group). *p<0.05, E1
group vs. E1 + P1 or E1 + P2 groups. c Effect of high dose of
estrogen (alone and combined administration) on the percentage
changes of AQP protein compared with that in vehicle, following
TBI in the OVX rats (n=6 in each group). Veh vehicle, E1 low
dose of estrogen, E2 high dose of estrogen, P1 low dose of
progesterone, P2 high dose of progesterone, E1 + P1 low dose
of estrogen + low dose of progesterone, E1 + P2 low dose of
estrogen + high dose of progesterone, E2 + P1 high dose of
estrogen + low dose of progesterone, E2 + P2 high dose of
estrogen + high dose of progesterone. Data are presented as
mean±SEM. The AQP protein in the brain was quantified by
Western blot analysis
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Fig. 3b, c. The AQP4 protein significantly decreased
in the E1 group (−53.47±15.62 %) compared with
that in the E1 + P1 (40.67±8.85 %) and E1 + P2
(57.05±41.7 %) groups (p<0.05) (Fig. 3b). The
change in the AQP4 protein content was not signif-
icantly different between the E2 group (−55.14±
14.48 %) and the E2 + P1 (52.03±42.08 %) and
E2 + P2 (50.89±36.81 %) groups (Fig. 3c).
Brain IL-6 levels following treatment in TBI
The effect of different doses of ovarian steroid hor-
mones on the brain IL-6 levels post-TBI in the
ovariectomized rats is shown in Fig. 4. The injured
animals treated with E1 (573.13±37.15 pg/mL) had
lower levels of IL-6 than that in the vehicle (1068±
54.18 pg/mL, p<0.001), E2 (900.13±77.17 pg/mL,
p<0.05), and P2 (984.86±43.5 pg/mL, p<0.001)-
treated animals. The amount of IL-6 was not statis-
tically different between the E1 group and the P1
group (852.46±99.14 pg/mL) (Fig. 4a). The effect
of low or high dose of estrogen (alone and combined
administration) on the percentage changes of IL-6
levels compared with that in the vehicle group is
shown in Fig. 4b, c. The deceasing IL-6 was statis-
tically stronger in E1 (−41.53±5.66 %) group com-
pared with that in the E1 + P1 (73.58±25.78 %) and
E1 + P2 (85±24.54 %) groups (p<0.01) (Fig. 4b).
The amount of IL-6 (−13.79±8.57 %) was not sta-
tistically different between the E2 group and the E2
+ P1 (14.52±7.28 %) and E2 + P2 (27.16±13.25 %)
groups (Fig. 4c).
Discussion
We reported for the first time the effect of low and high
doses of progesterone and estrogen administered alone
and in combination, on the brain edema, the levels of
brain IL-6, and the expression of brain AQP4 in TBI. In
this study, the decrease of brain water content was found
in response to the low and high doses of progesterone
and estrogen administered post-TBI. This decrease was
attenuated when progesterone and estrogen were admin-
istered in combination. We suggest that these changes in
the brain water content may be mediated by changing
the levels of brain IL-6 and AQP4.
Brain edema plays a main role in the pathophysiolo-
gy of TBI and contributes to the mortality found in these
patients [16]. To date, no specific pharmaceutical ap-
proach exists for prevention or treatment of the brain
edema.
A number of reports have suggested that female
gonadal hormones may be responsible for the decrease
of edema formation post-TBI in the female animals [24,
31]. It has been shown that the administration of low [6]
and high [30] doses of estrogen dramatically causes the
decrease of ischemic volume following cerebral ische-
mia. On the other hand, it has been shown that the
exogenous progesterone has a dose- and time-
dependent neuroprotective effect in the experimental
stroke [21]. Therefore, in this study, the effect of pro-
gesterone and estrogen (low and high doses), alone and
in combination, was evaluated in ovariectomized female
rats following TBI.
Results of the present study showed that brain water
content significantly increased following TBI compared
with the sham group about 3 % (data not shown). Our
results also showed that both the low dose
(physiological) and the high dose (pharmacological) of
estrogen and progesterone decreased the brain water
content. The inhibitory effect of estrogen on the brain
water content was attenuated as a result of estrogen and
progesterone administration. The beneficial effect of
steroid administration alone on brain edema has been
reported in other studies [22, 31]. A study has shown
that progesterone causes the decrease of estrogen recep-
tor expression in the brain [11].
In this study, it was supposed that the probable neu-
roprotective mechanisms of the steroids on the brain
edema are affecting the AQP4 expression and the IL-6
levels in the injured brain. AQP4 mRNA and protein
and IL-6 levels in the brain significantly increased
Fig. 4 a Effect of estrogen or progesterone on the brain levels of
IL-6 (pg/mL) following traumatic brain injury (TBI) in the
ovariectomized (OVX) rats (n=6 in each group). ***p<0.001,
E1 group vs. vehicle group. ###p<0.001, E1 group vs. P2
group. ¶p<0.05, E1 group vs. E2 group. b Effect of low dose of
estrogen (alone and combined administration) on the percent
changes of IL-6 levels compared with that in vehicle, following
TBI in the OVX rats (n=6 in each group). **p<0.01, E1 group vs.
E1 + P1 and E1 + P2 groups. c Effect of high dose of estrogen
(alone and combined administration) on the percent changes of IL-
6 levels compared with that in vehicle, following TBI in the OVX
rats (n=6 in each group). Veh vehicle, E1 low dose of estrogen, E2
high dose of estrogen, P1 low dose of progesterone, P2 high dose
of progesterone, E1 + P1 low dose of estrogen + low dose of
progesterone, E1 + P2 low dose of estrogen + high dose of
progesterone, E2 + P1 high dose of estrogen + low dose of
progesterone, E2 + P2 high dose of estrogen + high dose of
progesterone. Data are presented as mean±SEM
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following TBI compared with the sham group, 21.04,
28.62, and 70.1 %, respectively (data not shown) which
are consistent to the results from other studies [12, 40].
Our results showed that both high and low doses of
estrogen and progesterone decrease the brain expression
of AQP4 mRNA and protein. Several studies have dem-
onstrated that the decrease in the brain edema is associ-
ated with a decrease in the AQP4 levels, following estro-
gen and progesterone administration in an injured brain
[8, 29]. The AQP4 deficiency ameliorates the acute le-
sions (24 h), while it worsens the delayed lesions in the
later phase (7 and 14 days) of the brain injury in mice
[28]. Therefore, AQP4 overexpression may be important
in post-ischemic recovery processes in the chronic phase,
and early inhibition of the AQP4 expression in the brain
tissue may provide a new treatment approach for the
cerebral edema [27]. These results are in agreement with
ours. However, downregulation of AQP4 protein is re-
versed when estrogen and progesterone are administered
in combination, especially in the E1 + P1 and E1 + P2-
treated groups. Therefore, these steroids affected both
transcriptional and post-transcriptional processes when
administered alone, while their combination only affect-
ed post-transcriptional processes in agreement with other
investigations [38].When progesteronewas administered
with estrogen in, it decreased effect of E1 on water
content, compatible with the decrease of estrogen effect
on AQP4 protein.
The present study showed that only low dose of
estrogen significantly decreased the brain levels of IL-
6. The inhibitory effect of estrogen on the IL-6 expres-
sion has been demonstrated in the monocytes [14].
However, this downregulation is inverted, when a com-
bination of low doses of estrogen and progesterone is
administered. The changes of brain edema, AQP4 ex-
pression, and IL-6 levels may be a result of the inhibi-
tion of expression of the estrogen receptor by progester-
one [11] in the combined administration groups. Several
investigators have suggested that increasing IL-6 ex-
pression may contribute to the development of post-
trauma responses including brain edema [37, 39].
Based on the results of the present study, two plausi-
ble mechanisms are needed to be considered for the anti-
edema effect of steroids: (1) an inhibitory effect on the
brain AQP4 expression and (2) an anti-inflammatory
effect (decreasing brain IL-6). Three neuroprotective
mechanisms are suggested to the inhibitory effect of
steroids on the expression of AQP4. Firstly, since cyto-
kines promote the AQP4 overexpression [4], steroids
probably attenuate the brain edema by inhibiting IL-6-
induced AQP-4 expression. Secondly, increasing ex-
pression of hypoxia-inducible factor 1-alpha (HIF-1α)
may play a central role in brain edema and BBB disrup-
tion by increasing both AQP4 and MMP-9 in TBI [9].
Therefore, steroids may decrease the brain edema by
inhibiting HIF-1α-induced AQP4 expression. Finally,
steroids may decrease the brain edema by a direct effect
on AQP4 expression via the genomic and nongenomic
mechanisms.
Overall, the present study showed that the adminis-
tration of different doses of estrogen or progesterone led
to decreasing brain edema following TBI. In addition to
other neuroprotective mechanisms employed by estro-
gen and progesterone, a decrease in the brain AQP4
expression and IL-6 levels should also be considered.
It was also shown that co-administration of estrogen and
progesterone may decrease the neuroprotective effect of
individual administration of estrogen or progesterone on
the brain edema. The latter is consistent with the de-
crease of inhibitory effect of estrogen on the brain levels
of IL-6 and the brain expression of AQP4. Further
studies are necessary to find the mechanism(s) and
receptors involved in the interaction of sex steroids,
AQP4 expression, and IL-6 levels in the brain.
Conclusions
Individual administration of estrogen or progesterone
attenuated the development of brain edema post-TBI,
probably by decreasing the brain AQP4 expression and
IL-6 levels. The co-administration of estrogen and pro-
gesterone suggested decreases of inhibitory effects
probably by increasing the brain expression of AQP4
and the brain levels of IL-6. Further studies are required
to verify these mechanisms.
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